New drug for ALS provides hope for patients
from By Dr. Abimbola Farinde
Amyotrophic lateral sclerosis (ALS) is regarded as a progressive neurological condition that has the ability to destroy the nerve cells and lead to complete disability in the affected individual. Given the debilitating nature of ALS, the recent approval of a new drug for treating ALS is considered to be a milestone. Edaravone is only the second drug to ever be approved by the FDA for the treatment of ALS — and the first in more than two decades since riluzole in 1995.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063